Business UpdateJul 13, 2026, 07:01 AM
Tonix Secures Medicare Agreement for TONMYA, Adding 9M Lives
AI Summary
Tonix Pharmaceuticals announced a major managed Medicare agreement for TONMYA, effective January 1, 2027, adding approximately 9 million Medicare lives. This expands TONMYA's total pharmacy coverage to about 145 million covered lives, representing 46% of all covered lives in the U.S., building on previous commercial and Medicaid agreements. Following these coverage milestones, Tonix is expanding its sales force by 50 new representatives by mid-Q3 2026, bringing the total to 150, to capitalize on the increased patient access.
Key Highlights
- New Medicare agreement for TONMYA adds approximately 9 million Medicare lives.
- Agreement effective January 1, 2027, covering 16% of U.S. Medicare lives.
- Total pharmacy coverage for TONMYA will reach 145 million covered lives (46% of U.S. total).
- Sales force to expand by 50 new representatives by mid-third quarter 2026.
- Total sales force will reach approximately 150 people.
- TONMYA is the first new fibromyalgia treatment approved in over 15 years.
Price Impact
More from TNXP